EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immunogenetic Signature of the MICA‐129 Val/Val Genotype Associated With Metastasis in Melanoma

Bruna Somilio da Fonseca iD, Bruna D L Fragelli iD, Joice M A Rodolpho iD, Krissia F Godoy iD, Camila F B Castro iD, Erick C Casteli iD, Lucas R Azevedo iD, Izabela A Lopes iD, Luciana Benevides iD, Fernanda F Anibal iD

Journal of Immunology Research · 2026-01 · 2026 (1)

DOI: 10.1155/jimr/2883849 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Immunology Research, online erschienen am 01.11.2026. Verfasst von Bruna Somilio da Fonseca und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Inflammation and Infectious Diseases, Federal University of São Carlos (UFSCar), 13565-908, São Carlos, SP, Brazil, ufscar.br. Hauptthemen laut MEDLINE: Melanoma, Histocompatibility Antigens Class I, Genotype. Die Arbeit nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Petrobras.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MICA (major histocompatibility complex class I [MHC class I] chain‐related protein A) is a stress‐induced glycoprotein that functions as a ligand for the NKG2D (natural killer [NK] group 2 member D) receptor, expressed on NK cells and CD8 + T lymphocytes (cytotoxic T cells), playing a key role in tumor immune surveillance. In melanoma, modulation of this axis promotes tumor immune evasion. The functional MICA‐129 polymorphism (methionine [Met]/valine [Val]) alters the binding affinity to NKG2D, thereby influencing the cytotoxic immune response. This study included patients with basal cell carcinoma (BCC) and melanoma (primary and metastatic). The Functional Assessment of Cancer Therapy–Melanoma (FACT‐M) questionnaire was administered, followed by MICA‐129 genotyping using quantitative polymerase chain reaction (qPCR), measurement of soluble MICA (sMICA) by enzyme‐linked immunosorbent assay (ELISA), analysis of MICA and NKG2D expression on CD8 + T lymphocytes by flow cytometry, and assessment of inflammatory cytokines and angiogenic factors. A higher frequency of the Val/Val genotype was observed in metastatic melanoma, whereas serum sMICA levels did not differ among the groups. The Val variant was associated with reduced functional stability of the MICA–NKG2D axis, favoring tumor immune evasion. Primary melanoma exhibited a more pronounced inflammatory profile, whereas metastatic melanoma showed greater angiogenic activity, indicating a microenvironment conducive to tumor progression. These findings suggest that the MICA‐129 Val/Val genotype may serve as a prognostic biomarker and support the MICA–NKG2D axis as a potential therapeutic target in melanoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaHistocompatibility Antigens Class IGenotypeHumansNK Cell Lectin-Like Receptor Subfamily KFemaleMaleMiddle AgedAgedNeoplasm MetastasisCD8-Positive T-LymphocytesGenetic Predisposition to DiseaseCytokinesAdultSkin Neoplasms

Stichwörter der Autor:innen

MHC class I-related chain A (MICA)NKG2D receptorcytokinesgenetic polymorphismmelanoma

Substanzen

Histocompatibility Antigens Class IMHC class I-related chain ANK Cell Lectin-Like Receptor Subfamily KKLRK1 protein, humanCytokines

Autor:innen und Institutionen

  • Laboratory of Inflammation and Infectious Diseases, Federal University of São Carlos (UFSCar), 13565-908, São Carlos, SP, Brazil, ufscar.br.
  • Padre Albino University Centre - UNIFIPA, 15809-144, Catanduva, Brazil.
  • Molecular Genetics and Bioinformatics Laboratory-Experimental Research Unit, School of Medicine, São Paulo State University (UNESP) Botucatu, 18618-687, Botucatu, SP, Brazil, unesp.br.
  • Fiocruz Ribeirão Preto, Oswaldo Cruz Foundation (Fiocruz), 14049-900, Ribeirão Preto, SP, Brazil, fiocruz.br.

ORCID-Profile: Bruna Somilio da Fonseca, Bruna D L Fragelli, Joice M A Rodolpho, Krissia F Godoy, Camila F B Castro, Erick C Casteli, Lucas R Azevedo, Izabela A Lopes, Luciana Benevides, Fernanda F Anibal

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Petrobras

Zitieren

APA

Fonseca, B. S. D., Fragelli, B. D. L., Rodolpho, J. M. A., Godoy, K. F., Castro, C. F. B., Casteli, E. C., Azevedo, L. R., Lopes, I. A., Benevides, L., & Anibal, F. F. (2026). Immunogenetic Signature of the MICA‐129 Val/Val Genotype Associated With Metastasis in Melanoma. Journal of Immunology Research, 2026(1). https://doi.org/10.1155/jimr/2883849

Vancouver

Fonseca BSD, Fragelli BDL, Rodolpho JMA, Godoy KF, Castro CFB, Casteli EC, et al. Immunogenetic Signature of the MICA‐129 Val/Val Genotype Associated With Metastasis in Melanoma. Journal of Immunology Research. 2026;2026(1). doi:10.1155/jimr/2883849

BibTeX
@article{Fonseca2026,
  author = {Fonseca, Bruna Somilio da and Fragelli, Bruna D L and Rodolpho, Joice M A and Godoy, Krissia F and Castro, Camila F B and Casteli, Erick C and Azevedo, Lucas R and Lopes, Izabela A and Benevides, Luciana and Anibal, Fernanda F},
  title = {Immunogenetic Signature of the MICA‐129 Val/Val Genotype Associated With Metastasis in Melanoma},
  journal = {Journal of Immunology Research},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/jimr/2883849}
}
Kostenlos starten →